Publication | Open Access
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial.
192
Citations
28
References
2021
Year
Controlled TrialCovid-19 PandemicClinical TrialsAntiviral TherapyCovid-19-a Double-blindCovid-19 EpidemiologyAntiviral DrugMedicineCovid-19
| Year | Citations | |
|---|---|---|
Page 1
Page 1